We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLRO icon
10526
ClearOne Inc
CLRO
$11.2M
$38K ﹤0.01%
+1,125
New +$35.8K
DRRX
10527
CALL
DELISTED
DURECT Corp
DRRX
$38K ﹤0.01%
1,850
-2,020
-52% -$38.4K
GERN icon
10528
Geron
GERN
$821M
$38K ﹤0.01%
24,121
-181,428
-88% -$331K
INFI
10529
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$38K ﹤0.01%
+18,000
New +$29.7K
STAB
10530
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$38K ﹤0.01%
+11,155
New +$31.8K
HWCC
10531
DELISTED
Houston Wire & Cable Company
HWCC
$38K ﹤0.01%
13,537
+137
+1% +$372
ASRT
10532
CALL
DELISTED
Assertio
ASRT
$37K ﹤0.01%
1,710
+522
+44% +$16.2K
ATXS
10533
PUT
DELISTED
Astria Therapeutics
ATXS
$37K ﹤0.01%
2,900
+583
+25% +$10.4K
TAIT
10534
DELISTED
Taitron Components
TAIT
$37K ﹤0.01%
+11,495
New +$30.8K
TK icon
10535
CALL
Teekay
TK
$1.03B
$37K ﹤0.01%
+17,000
New +$38.3K
TONX
10536
TON Strategy Co
TONX
$173M
$37K ﹤0.01%
3
+1
+50% +$10K
LEJU
10537
PUT
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$37K ﹤0.01%
+1,610
New +$37.9K
RTP.WS
10538
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$37K ﹤0.01%
+11,526
New +$31.2K
NAVB
10539
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$37K ﹤0.01%
17,295
-9,197
-35% -$21.7K
KOS icon
10540
PUT
Kosmos Energy
KOS
$1.5B
$36K ﹤0.01%
15,500
+1,300
+9% +$2.06K
LXU icon
10541
LSB Industries
LXU
$707M
$36K ﹤0.01%
13,898
-44,531
-76% -$80.9K
SCKT icon
10542
Socket Mobile
SCKT
$3.39M
$36K ﹤0.01%
+15,091
New +$34.5K
TC
10543
TuanChe
TC
$51.8M
$36K ﹤0.01%
35
+23
+192% +$24.9K
BYU
10544
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$36K ﹤0.01%
92
-25
-21% -$14K
NEPT
10545
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$36K ﹤0.01%
17
SREV
10546
PUT
DELISTED
ServiceSource International, Inc.
SREV
$36K ﹤0.01%
20,500
-3,000
-13% -$4.44K
GNCA
10547
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$36K ﹤0.01%
14,700
-6,000
-29% -$13.7K
EDTK icon
10548
Skillful Craftsman
EDTK
$14.4M
$35K ﹤0.01%
+11,312
New +$34.7K
NEPT
10549
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$35K ﹤0.01%
16
-46
-74% -$118K
MARK
10550
DELISTED
Remark Holdings, Inc.
MARK
$35K ﹤0.01%
1,833
-6,983
-79% -$95.2K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.